These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17353571

  • 1. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF, McKeon MR, Weiss WT.
    Am J Health Syst Pharm; 2007 Mar 15; 64(6):622-31. PubMed ID: 17353571
    [Abstract] [Full Text] [Related]

  • 2. Does your pharmacy have a compounding isolator?
    LaBella CJ.
    Am J Health Syst Pharm; 2007 Apr 15; 64(8):855-8. PubMed ID: 17420203
    [No Abstract] [Full Text] [Related]

  • 3. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA, Gentempo JA, Saenz LM, Woodard MY, Angeles CH.
    Am J Health Syst Pharm; 2007 Apr 15; 64(8):837-41. PubMed ID: 17420200
    [Abstract] [Full Text] [Related]

  • 4. Microbial contamination of syringes during preparation: the direct influence of environmental cleanliness and risk manipulations on end-product quality.
    Stucki C, Sautter AM, Favet J, Bonnabry P.
    Am J Health Syst Pharm; 2009 Nov 15; 66(22):2032-6. PubMed ID: 19890087
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD.
    Int J Pharm Compd; 2014 Nov 15; 18(1):46-52. PubMed ID: 24881341
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators.
    Mulder K.
    Int J Pharm Compd; 2019 Nov 15; 23(6):447-452. PubMed ID: 31751940
    [Abstract] [Full Text] [Related]

  • 16. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH, Franssen EJF, Pilesi F, Crul M.
    Eur J Pharm Sci; 2019 Mar 15; 130():181-185. PubMed ID: 30710619
    [Abstract] [Full Text] [Related]

  • 17. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S, Ljungqvist B, Reinmüller B.
    PDA J Pharm Sci Technol; 2009 Mar 15; 63(1):71-80. PubMed ID: 19455943
    [Abstract] [Full Text] [Related]

  • 18. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM, Weiss WT, McCluskey SV.
    Am J Health Syst Pharm; 2008 Jul 01; 65(13):1266-9. PubMed ID: 18574018
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sterile Product Packaging and Delivery Systems.
    Akers MJ.
    Int J Pharm Compd; 2015 Jul 01; 19(6):491-500. PubMed ID: 26891564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.